Mode
Text Size
Log in / Sign up
N/A N=16 Diagnostic

Assessing Ventilator Safety in Patients on Pressure-Support Ventilation

Acute Respiratory Failure · Mechanical Ventilation Complication · Ventilator-Induced Lung Injury

Enrolled (actual)
16
Serious AEs
6.7%
Results posted
Oct 2025
Primary outcome: Primary: Respiratory System Driving Pressure Measure by Servo Ventilator (DPrs-servo) — 12.3 centimeters of water

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Viasys Avea Ventilator (Device); Philips Respironics NM3 device (Device); Servo U ventilator (Device); Vyaire SmartCath adult nasogastric tube with Esophageal balloon (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Duke University
Primary completion
Nov 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Respiratory System Driving Pressure Measure by Servo Ventilator (DPrs-servo)
12.3
PRIMARY
Respiratory System Driving Pressure Measure by Respironics NM3 Device (DPrs-NM3)
8.8
PRIMARY
Airway Occlusion Test (AOC)
17.4
PRIMARY
Respiratory System Driving Pressure Measured During Volume Control Breath.
12.3
PRIMARY
Transpulmonary Driving Pressure Measured During Volume Control Breath.
9.5
SECONDARY
Duration of Mechanical Ventilation
12.4
SECONDARY
Duration of Intensive Care Unit Admission
17.2
SECONDARY
Duration of Hospital Admission
28
SECONDARY
Ventilator Free Days
16
SECONDARY
In-hospital Survival
7

Summary

ASOP is a prospective cohort study comparing three methods for assessing risk of self-induced lung injury in patients with acute respiratory failure being managed with pressure-support ventilation. We will describe the relationship between three different assessment methods for risk of self-induced lung injury and compare them to a gold standard measurement.

Eligibility Criteria

Inclusion Criteria

  • Adult patients age ≥18 years with acute respiratory failure receiving invasive mechanical ventilation
  • Managed in pressure-support mode of ventilation

Exclusion Criteria

  • Actively undergoing a spontaneously awakening trial or SAT
  • Patient or surrogate is unable to provide informed consent
  • Currently pregnant
  • Currently incarcerated
  • Acute exacerbation of an obstructive lung disease
  • Known esophageal varices or any other condition for which the attending physician deems an orogastric catheter to be unsafe
  • Esophageal, gastric or duodenal surgical procedures within the last 6 months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05125952). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search